美康生物：肝素结合蛋白检测试剂盒(化学发光免疫分析法)取得医疗器械注册证

Core Viewpoint - Meikang Bio (300439.SZ) announced that its subsidiary, Jiangxi Meikang Shengde Biotechnology Co., Ltd., has obtained the Medical Device Registration Certificate for in vitro diagnostic reagents from the Jiangxi Provincial Drug Administration, specifically for the "Heparin-Binding Protein Test Kit (Chemiluminescent Immunoassay)" [1] Group 1 - The acquisition of the registration certificate enhances the product line in the niche market of in vitro diagnostic chemiluminescence [1] - This development is expected to strengthen the company's core competitiveness and market expansion capabilities [1] - The positive impact on the company's future operations is anticipated as a result of this certification [1]